IMPACT: IMplementation of Physical Activity for Children and Adolescents on Treatment
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age5-18
SponsorUniversity of Calgary
About this trial
Physical activity can enhance well-being among youth diagnosed with oncological or hematological diseases. We developed a tailored, 1:1, online physical activity program (i.e., IMPACT), to promote physical activity in this cohort. The proposed single-group, mixed-methods project will assess the effect of IMPACT and explore markers of implementation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Children or adolescents between the ages of 5-18 years at enrollment and at least one parent (defined as a caregiver; biological or otherwise)
Diagnosed with any oncological and/or hematological diagnosis
Currently receiving or scheduled to receive any treatment for any oncological and/or hematological diagnosis or completed treatment <3 months
Disqualifiers
Completed all treatment for their oncological or hematological diagnosis >3 months
Unable to participate in physical activity as assessed by the patients' healthcare team or physical activity specialist
Parent and/or patient cannot understand verbal English
Parent is unwilling to be present (i.e., at home, in the same room depending on participant age and functional ability) during the physical activity sessions (required to ensure safety of the child/adolescent)
Trial design
Design model
Single group
Treatments tested in this trial
Physical Activity
BehavioralParticipants will receive the IMPACT program, which includes a combination of aerobic, resistance, balance, and flexibility exercises conducted 1:1 and delivered online by a physical activity specialist via Zoom. The IMPACT program follows basic physical activity progression principles (i.e., principles of frequency, intensity, time, type, overload and progression). Tailoring will be used to promote fitness and wellness benefits, while ensuring safety. In addition, prominent behaviour change techniques will be provided by physical activity specialists within each 1:1 session. Discussions and worksheets will be provided, depending on participants needs.
Treatment groups
250 Participants
are divided into 1 treatment groupGroup A: Physical activityExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Reach
The number of people who participate, and reasons why or why not.
Time frame
Through study completion, an average of 6 years.Secondary outcomes
1
Attendance
Number of sessions attended out of the number of sessions offered by study staff.
Time frame
Through study completion, an average of 6 years.2
Adherence
Number of assessments completed out of number of scheduled assessments.
Time frame
Through study completion, an average of 6 years.3
Self-Reported Physical Activity Behaviour
Modified Leisure Time Exercise Questionnaire (Godin \& Shephard, 1985). Time spent in mild, moderate, and vigorous activity will be calculated. Higher numbers indicate greater physical activity.
Time frame
Baseline (week 0), post-intervention (week 8-12), 6-month follow-up (week 20-24), 1 year follow-up (week 48-52)4
Directly Assessed Physical Activity Behaviour
7-day wear period (minimum) with an activity monitor. Higher numbers indicate greater time spent in physical activity and intensity.
Time frame
Baseline (week 0), post-intervention (week 8-12), 6-month follow-up (week 20-24), 1 year follow-up (week 48-52)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Calgary
Lead sponsor
Alberta Children's Hospital
Collaborator
Stollery Children's Hospital
Collaborator
Canadian Cancer Society (CCS)
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
Source ClinicalTrials.gov